ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy||Massachusetts General Hospital / Bakhos Tannous, PhD||Innovation Grants||2018||Massachusetts|
|Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology||Children's Hospital of Philadelphia / Allison Barz Leahy, MD||Young Investigator Grants||2018||Pennsylvania|
|Physical Properties of Drug-Resistant Leukemia Cells||Children's Hospital Los Angeles / Yong-mi Kim, MD/PhD||Innovation Grants||2018||California|
|RNA Methylation in Metabolically Disrupted Pediatric Cancers||University of Texas Health Science Center at San Antonio / Patricia Dahia, MD/PhD||Innovation Grants||2018||Texas|
|RNA-ECS to Quantify Rare Clonal RNA Species at Diagnosis, Remission and Relapse from the COG AAML1031 Study||Washington University / Todd Druley, MD/PhD||Innovation Grants||2018||Missouri|
|Surviving Cancer CAMPetently: Evidence-based Care Delivered at Family Camp||Nemours A.I. duPont Hospital for Children / Melissa Alderfer, PhD||Psychosocial Family Impact Grant||2018||Delaware|
|Targeting Glutamine Addiction in Diffuse Intrinsic Pontine Gliomas (DIPGs)||University of Michigan / Sriram Venneti, MD/PhD||Innovation Grants||2018||Michigan|
|Targeting KDM6B in Pediatric Leukemia||Washington University / Grant A. Challen, PhD||Innovation Grants||2018||Missouri|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|